Renal Cancer
AN INTERVENTIONAL PHASE 1B/2 STUDY TO EVALUATE THE SAFETY AND EFFICACY OF PF-08634404 MONOTHERAPY AND IN COMBINATION WITH OTHER ANTICANCER AGENTS IN ADULT PARTICIPANTS WITH LOCALLY ADVANCED OR METASTATIC RENAL CELL CARCINOMA Code Number: C6461008
- Details
ClinicalTrials.gov ID:
NCT07227415
Diagnosis Type:
NA
USOR Number:
- Address
,
P: